Oral Ibuprofen Superior To Topical Diclofenac for Acute Low Back Pain, Study Finds
Acute low back pain is a common complaint in emergency departments (EDs), often leading to discomfort and functional impairment. Nonsteroidal anti-inflammatory drugs (NSAIDs), including oral ibuprofen and topical diclofenac, are commonly used to manage musculoskeletal pain. However, the comparative efficacy of these medications in the treatment of acute nonradicular musculoskeletal low back pain remains uncertain.
A recent study was published in the journal of Annals of Emergency Medicine by Nauman K. and colleagues. A randomized, placebo-controlled double-blind study was conducted among patients aged 18 to 69 years presenting to the ED with acute, nontraumatic, nonradicular musculoskeletal low back pain. Participants were randomized to receive one of three treatments: oral ibuprofen + placebo topical gel, 1% diclofenac topical gel + oral placebo, or a combination of oral ibuprofen + 1% diclofenac topical gel. The primary outcome measure was the change in Roland Morris Disability Questionnaire (RMDQ) score between ED discharge and 2 days later.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.